Breaking News

 
01 September 2010
Atopic dermatitis not associated with deletion of late cornified envelope 3b and 3C genes
 
31 August 2010
Ustekinumab yields sustained response in phase II and III trials in plaque psoriasis
 
30 August 2010
Briakinumab is safe and efficacious in phase II and III trials in psoriasis
 
27 August 2010
Late cornified envelope deletion as a risk factor for psoriatic arthritis
 
26 August 2010
Psychophysical aspects of hidradenitis suppurativa
 
25 August 2010
Low-dose Q-switched Nd:YAG laser treatment of melasma
 
24 August 2010
Development of three screening tools to identify psoriatic arthritis
 
23 August 2010
Filaggrin null mutations and their association with contact allergy and allergic contact dermatitis
 
20 August 2010
Obesity as a risk factor for psoriatic arthritis
 
19 August 2010
Quality of life in patients with lepromatous leprosy in China
 
18 August 2010
Application of DAREA/DAPSA score to assess psoriatic arthritis disease activity
 
17 August 2010
C-reactive protein and leukocyte activation as potential monitors of psoriasis vulgaris severity and therapy
 
16 August 2010
Malignancy concerns with various psoriasis treatments: a review
 
13 August 2010
Detection of subclinical and clinical actinic keratosis during imiquimod treatment
 
12 August 2010
Infliximab monotherapy in plaque psoriasis and psoriatic arthritis: a multicenter, randomized placebo-controlled trial
 
11 August 2010
Prednisone and mycophenolate mofetil in treating pemphigus vulgaris: a multicenter, randomized, placebo-controlled trial
 
11 August 2010
Prednisone and mycophenolate mofetil in treating pemphigus vulgaris: a multicenter, randomized, placebo-controlled trial
 
09 August 2010
Response to cyclosporine therapy and high-sensitivity C-reactive protein levels in chronic idiopathic urticaria
 
06 August 2010
Guidelines for the management of pediatric tinea capitis
 
05 August 2010
Clinical features and treatment outcomes of vitiligo from the patients’ perspective